At Strand Therapeutics, Jake Becraft and Tasuku Kitada are moving research with roots in the Weiss and Irvine labs toward the clinic, by creating mRNA therapies that instruct tumors to produce signals that make them visible to the immune system.
At Strand Therapeutics, Jake Becraft and Tasuku Kitada are moving research with roots in the Weiss and Irvine labs toward the clinic, by creating mRNA therapies that instruct tumors to produce signals that make them visible to the immune system.